Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis AM Petrich, M Gandhi, B Jovanovic, JJ Castillo, S Rajguru, DT Yang, ... Blood, The Journal of the American Society of Hematology 124 (15), 2354-2361, 2014 | 519 | 2014 |
Introduction to flow cytometry JM Jaso Introduction to flow cytometry, 1991 | 245 | 1991 |
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms SA Wang, RP Hasserjian, PS Fox, HJ Rogers, JT Geyer, ... Blood, The Journal of the American Society of Hematology 123 (17), 2645-2651, 2014 | 223 | 2014 |
Adenoid cystic carcinoma J Jaso, R Malhotra Archives of pathology & laboratory medicine 135 (4), 511-515, 2011 | 197 | 2011 |
Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients BE Adrada, RN Miranda, GM Rauch, E Arribas, R Kanagal-Shamanna, ... Breast cancer research and treatment 147, 1-14, 2014 | 183 | 2014 |
Multi-color flow cytometric immunophenotyping for detection of minimal residual disease in AML: past, present and future JM Jaso, SA Wang, JL Jorgensen, P Lin Bone marrow transplantation 49 (9), 1129-1138, 2014 | 92 | 2014 |
Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma DJ Landsburg, AM Petrich, JS Abramson, AR Sohani, O Press, ... Cancer 122 (4), 559-564, 2016 | 91 | 2016 |
Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B‐lymphoblastic leukemia in the era of tyrosine kinase inhibitors J Jaso, DA Thomas, K Cunningham, JL Jorgensen, HM Kantarjian, ... Cancer 117 (17), 4009-4017, 2011 | 73 | 2011 |
Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems B Fu, JM Jaso, RL Sargent, M Goswami, S Verstovsek, LJ Medeiros, ... Modern pathology 27 (5), 681-689, 2014 | 58 | 2014 |
CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases J Jaso, L Chen, S Li, P Lin, W Chen, RN Miranda, S Konoplev, ... Human pathology 43 (9), 1436-1443, 2012 | 53 | 2012 |
Upper airway mucus deposition in lung tissue of burn trauma victims RA Cox, RP Mlcak, DL Chinkes, S Jacob, P Enkhbaatar, J Jaso, LP Parish, ... Shock 29 (3), 356-361, 2008 | 47 | 2008 |
Clinicopathologic features of CD5-positive nodal marginal zone lymphoma JM Jaso, CC Yin, SA Wang, RN Miranda, CE Jabcuga, L Chen, ... American journal of clinical pathology 140 (5), 693-700, 2013 | 33 | 2013 |
Bright CD38 expression by flow cytometric analysis is a biomarker for double/triple hit lymphomas with a moderate sensitivity and high specificity A Alsuwaidan, E Pirruccello, J Jaso, P Koduru, R Garcia, JE Krueger, ... Cytometry Part B: Clinical Cytometry 96 (5), 368-374, 2019 | 32 | 2019 |
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes B Fu, CY Ok, M Goswami, W Xei, JM Jaso, T Muzzafar, C Bueso-Ramos, ... Annals of hematology 92, 1335-1343, 2013 | 26 | 2013 |
Breast implant-associated plasmablastic lymphoma: a case report and discussion of the literature PR Geethakumari, J Markantonis, JL Shah, A Alsuwaidan, I Shahab, ... Clinical Lymphoma Myeloma and Leukemia 19 (10), e568-e572, 2019 | 14 | 2019 |
A synoptic reporting system for peripheral blood smear interpretation J Jaso, A Nguyen, AND Nguyen American journal of clinical pathology 135 (3), 358-364, 2011 | 13 | 2011 |
SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia NCJ Lee, B Patel, A Etra, T Bat, IF Ibrahim, M Vusirikala, M Chen, ... Blood Advances 6 (13), 3840-3843, 2022 | 12 | 2022 |
Burkitt lymphoma presenting as a mass in the thyroid gland: a clinicopathologic study of 7 cases and review of the literature AE Quesada, H Liu, RN Miranda, N Golardi, S Billah, LJ Medeiros, ... Human Pathology 56, 101-108, 2016 | 12 | 2016 |
B acute lymphoblastic leukemia with t (14; 19)(q32; p13. 1) involving IGH/EPOR: a clinically aggressive subset of disease JM Jaso, CC Yin, VW Lu, M Zhao, LV Abruzzo, MJ You, Y Yang, R Luthra, ... Modern Pathology 27 (3), 382-389, 2014 | 12 | 2014 |
Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma—A Unique Entity: A Report of Two Cases With Low-Level Bone Marrow Involvement and Review of the Literature SK Germans, O Kulak, P Koduru, D Oliver, J Gagan, P Patel, ... American journal of clinical pathology 154 (6), 816-827, 2020 | 11 | 2020 |